Study Title: A Phase 3, Multicenter, Open-label, Randomized Study to Compare the Efficacy and Safety of MK-2870 Versus Treatment of Physicians Choice in 3L+ Advanced/Metastatic Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Albert Lockhart, at lockhara@musc.edu.Study Coordinator, Bria Sanders, at sandebri@musc.edu.Trial opened at the following institutions: Medical University of South Carolina